A Placebo-Controlled, Two-Part Study, Oral Dose to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of CNTX-6970 in Healthy Subjects
Completed · Phase 1 · Has a placebo group
Conditions studied: Chronic Pain, Nociceptive Pain
In brief
A Phase 1, placebo-controlled, two part study with either single dose or multiple increasing oral dose to evaluate the safety, pharmacokinetics, and pharmacodynamics of CNTX-6970 in healthy subjects.
Key facts
- Study ID
- NCT03787004
- Run by
- Centrexion Therapeutics
- People needed
- 62
- Starts
- 2017-08-14
- Expected to finish
- 2018-09-26
- Last updated by the study team
- 2018-12-26
Who can join
Age: 18 and older, up to 64. Sex: any. Healthy volunteers: accepted.
Where it is running
- Medpace Clinical Pharmacology Unit — Cincinnati, Ohio, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.